TY - JOUR
T1 - The absence of ABCD2 sensitizes mice to disruptions in lipid metabolism by dietary erucic acid
AU - Liu, Jingjing
AU - Liang, Shuang
AU - Liu, Xiaoxi
AU - Brown, J. Andrew
AU - Newman, Kylie E.
AU - Sunkara, Manjula
AU - Morris, Andrew J.
AU - Bhatnagar, Saloni
AU - Li, Xiangan
AU - Pujol, Aurora
AU - Graf, Gregory A.
PY - 2012/6
Y1 - 2012/6
N2 - ABCD2 (D2) is a peroxisomal transporter that is highly abundant in adipose tissue and promotes the oxidation of long-chain MUFA. Erucic acid (EA, 22:1ω9) reduces very long chain saturated fatty acids in patients with X-linked adrenoleukodystrophy but promotes dyslipidemia and dilated cardiomyopathy in rats. To determine the role of D2 in the metabolism of EA, we challenged wild-type and D2 defi- cient mice (D2 KO) with an enriched EA diet. In D2 KO mice, dietary EA resulted in the rapid expansion of adipose tissue, adipocyte hypertrophy, hepatic steatosis, and the loss of glycemic control. However, D2 had no impact on the development of obesity phenotypes in two models of diet-induced obesity. Although there was a significant increase in EA in liver of D2 KO mice, it constituted less than 2% of all fatty acids. Metabolites of EA (20:1, 18:1, and 16:1) were elevated, particularly 18:1, which accounted for 50% of all fatty acids. These data indicate that the failure to metabolize EA in adipose results in hepatic metabolism of EA, disruption of the fatty acid profile, and the development of obesity and reveal an essential role for D2 in the protection from dietary EA.
AB - ABCD2 (D2) is a peroxisomal transporter that is highly abundant in adipose tissue and promotes the oxidation of long-chain MUFA. Erucic acid (EA, 22:1ω9) reduces very long chain saturated fatty acids in patients with X-linked adrenoleukodystrophy but promotes dyslipidemia and dilated cardiomyopathy in rats. To determine the role of D2 in the metabolism of EA, we challenged wild-type and D2 defi- cient mice (D2 KO) with an enriched EA diet. In D2 KO mice, dietary EA resulted in the rapid expansion of adipose tissue, adipocyte hypertrophy, hepatic steatosis, and the loss of glycemic control. However, D2 had no impact on the development of obesity phenotypes in two models of diet-induced obesity. Although there was a significant increase in EA in liver of D2 KO mice, it constituted less than 2% of all fatty acids. Metabolites of EA (20:1, 18:1, and 16:1) were elevated, particularly 18:1, which accounted for 50% of all fatty acids. These data indicate that the failure to metabolize EA in adipose results in hepatic metabolism of EA, disruption of the fatty acid profile, and the development of obesity and reveal an essential role for D2 in the protection from dietary EA.
KW - Adipocyte
KW - Adipose
KW - Adrenoleukodystrophy
KW - Fatty liver
KW - Insulin resistance
KW - Lorenzo's oil
KW - Peroxisome
UR - http://www.scopus.com/inward/record.url?scp=84861424351&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84861424351&partnerID=8YFLogxK
U2 - 10.1194/jlr.M022160
DO - 10.1194/jlr.M022160
M3 - Article
C2 - 22493092
AN - SCOPUS:84861424351
SN - 0022-2275
VL - 53
SP - 1071
EP - 1079
JO - Journal of Lipid Research
JF - Journal of Lipid Research
IS - 6
ER -